Annual EBITDA
Summary
- Current Value
- As of today, JNJ annual EBITDA is $33.63B, up +19.41% on
- Historical Performance
- JNJ annual EBITDA is up +19.34% over the past 3 years, up +21.40% over the past 5 years
- All-Time High Comparison
- JNJ annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JNJ annual EBITDA is +19.41% above its 3-year low of $28.16B reached on
- Sector Comparison
- JNJ annual EBITDA is higher than 100.00% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $33.63B | +19.4% | +19.3% | +21.4% | +70.2% | |
| Quarterly EBITDA | $8.58B | +6.3% | +11.1% | -1.4% | +58.1% | |
| TTM EBITDA | $33.64B | +17.7% | +14.3% | +18.0% | +71.2% | |
| Price | $221.32 | +43.5% | +37.5% | +31.1% | +232.5% | |
| PE Ratio | 25.59 | +49.3% | -24.0% | -14.2% | +69.5% | |
| Annual Revenue | $94.18B | +6.0% | +17.6% | +14.1% | +52.8% | |
| Annual EPS | $11.03 | +90.6% | +63.8% | +100.3% | +130.8% | |
| Annual EBIT | $25.60B | +22.9% | +20.7% | +25.1% | +52.2% | |
| Annual Net Income | $26.80B | +90.6% | +63.7% | +82.2% | +101.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $33.63B | at high | |
| 5Y | $33.63B | at high | |
| All | $33.63B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $28.16B | +19.4% | |
| 5Y | $27.70B | N/A | +21.4% |
| All | $754.80M | +4355.1% |
EBITDA History
FAQ
What is the current annual EBITDA of JNJ?
As of today, JNJ annual EBITDA is $33.63B
What is 1-year change in JNJ annual EBITDA?
JNJ annual EBITDA is up +19.41% year-over-year
What is 3-year change in JNJ annual EBITDA?
JNJ annual EBITDA is up +19.34% over the past 3 years
How far is JNJ annual EBITDA from its all-time high?
JNJ annual EBITDA is currently at its all-time high
How does JNJ annual EBITDA rank versus sector peers?
JNJ annual EBITDA is higher than 100.00% of companies in Healthcare sector
When is JNJ next annual earnings release?
As of today, the next annual earnings release for JNJ has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, JNJ quarterly EBITDA is $8.58B, up +16.09% on
- Historical Performance
- JNJ quarterly EBITDA is up +6.32% year-over-year, up +11.13% over the past 3 years
- All-Time High Comparison
- JNJ quarterly EBITDA is currently -3.49% below its historical high of $8.89B set on
- 3-Year Low Comparison
- JNJ quarterly EBITDA is +58.52% above its 3-year low of $5.41B reached on
- Sector Comparison
- JNJ quarterly EBITDA is higher than 99.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $8.58B | +16.1% | +6.3% | +11.1% | -1.4% | |
| Annual EBITDA | $33.63B | – | +19.4% | +19.3% | +21.4% | |
| TTM EBITDA | $33.64B | +1.5% | +17.7% | +14.3% | +18.0% | |
| Price | $221.32 | -8.1% | +43.5% | +37.5% | +31.1% | |
| PE Ratio | 25.59 | +17.3% | +49.3% | -24.0% | -14.2% | |
| Quarterly Revenue | $24.07B | -2.0% | +9.9% | +15.3% | +7.9% | |
| Quarterly EPS | $2.14 | +2.1% | -52.8% | +8302.7% | -7.7% | |
| Quarterly EBIT | $6.40B | +18.9% | +1.6% | +6.7% | -6.0% | |
| Quarterly Net Income | $5.24B | +2.3% | -52.4% | +1166.2% | -15.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.89B | -3.5% | |
| 3Y | $8.89B | -3.5% | |
| 5Y | $8.89B | -3.5% | |
| All | $8.89B | -3.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.39B | +16.1% | |
| 3Y | $5.41B | +58.5% | |
| 5Y | $5.41B | +58.5% | |
| All | -$5.40B | +259.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of JNJ?
As of today, JNJ quarterly EBITDA is $8.58B
What is JNJ quarterly EBITDA most recent change?
JNJ quarterly EBITDA was up +16.09% on March 31, 2026
What is 1-year change in JNJ quarterly EBITDA?
JNJ quarterly EBITDA is up +6.32% year-over-year
How far is JNJ quarterly EBITDA from its all-time high?
JNJ quarterly EBITDA is currently -3.49% below its historical high of $8.89B set on September 30, 2025
How does JNJ quarterly EBITDA rank versus sector peers?
JNJ quarterly EBITDA is higher than 99.81% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
TTM EBITDA
Summary
- Current Value
- As of today, JNJ TTM EBITDA is $33.64B, up +1.54% on
- Historical Performance
- JNJ TTM EBITDA is up +17.69% year-over-year, up +14.31% over the past 3 years
- All-Time High Comparison
- JNJ TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JNJ TTM EBITDA is +19.16% above its 3-year low of $28.23B reached on
- Sector Comparison
- JNJ TTM EBITDA is higher than 99.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $33.64B | +1.5% | +17.7% | +14.3% | +18.0% | |
| Annual EBITDA | $33.63B | – | +19.4% | +19.3% | +21.4% | |
| Quarterly EBITDA | $8.58B | +16.1% | +6.3% | +11.1% | -1.4% | |
| Price | $221.32 | -8.1% | +43.5% | +37.5% | +31.1% | |
| PE Ratio | 25.59 | +17.3% | +49.3% | -24.0% | -14.2% | |
| TTM Revenue | $96.36B | +2.3% | +7.9% | +13.5% | +14.4% | |
| TTM EPS | $8.65 | -21.7% | -3.9% | +80.9% | +52.8% | |
| TTM EBIT | $25.73B | +0.4% | +20.9% | +14.3% | +21.7% | |
| TTM Net Income | $21.04B | -21.5% | -3.5% | +77.4% | +39.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $33.64B | at high | |
| 3Y | $33.64B | at high | |
| 5Y | $33.64B | at high | |
| All | $33.64B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $28.58B | N/A | +17.7% |
| 3Y | $28.23B | +19.2% | |
| 5Y | $28.23B | +19.2% | |
| All | -$1.90B | +1874.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of JNJ?
As of today, JNJ TTM EBITDA is $33.64B
What is JNJ TTM EBITDA most recent change?
JNJ TTM EBITDA was up +1.54% on March 31, 2026
What is 1-year change in JNJ TTM EBITDA?
JNJ TTM EBITDA is up +17.69% year-over-year
How far is JNJ TTM EBITDA from its all-time high?
JNJ TTM EBITDA is currently at its all-time high
How does JNJ TTM EBITDA rank versus sector peers?
JNJ TTM EBITDA is higher than 99.91% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
EBITDA Formula
Data Sources & References
- JNJ Official Website www.jnj.com
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj
